DALLAS, Oct. 12, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring genetic analysis products maker Sequenom Inc. (Nasdaq:SQNM). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.

The investment report on Sequenom Inc. (Nasdaq:SQNM) should be of particular interest to other medical technology and biotechnology companies: Beckman Coulter Inc. (NYSE:BEC), Illumina Inc. (Nasdaq:ILMN), Myriad Genetics Inc. (Nasdaq:MYGN) and Affymetrix Inc. (Nasdaq:AFFX).

The full report is available at: http://www.stockpreacher.com/n/SQNM

Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher

Sequenom (SQNM) focuses on providing of products, services, diagnostic testing, applications and genetic analysis products that translate genomic science into solutions for biomedical research, translational research, molecular medicine, and agricultural and livestock applications. Its development and commercialization efforts in various diagnostic areas include non-invasive prenatal diagnostics, oncology, infectious diseases and other disorders.

Message Board Search for SQNM: http://www.boardcentral.com/boards/SQNM

In the report, the analyst notes:

"Shares of SQNM took a dip last week on word that results for its highly anticipated blood test for Down syndrome had been mishandled. In a regulatory filing late Monday, the Company stated, 'We are no longer relying on, and the public should no longer rely on, any of our previously announced test data and results for our noninvasive prenatal test for Down syndrome.'

"Despite the bad news, SQNM continues to believe in the science underlying the test, which is estimated to have one of the largest markets, according to Ian Clements, PhD, SQNM's head of corporate communications...The Company said it continues to believe that this fetal material, including nucleic acids, will provide important information about the genetic makeup of the fetus and that this information may become the basis for new diagnostic tests. Looking forward, the Company intends to continue its research and development program for the test."

To read the entire report visit: http://www.stockpreacher.com/n/SQNM

See what investors are saying about these stocks at: http://www.stockhideout.com/

StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com

StockPreacher.com Disclosure

StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.

CONTACT:  StockPreacher.com
          Jeff Bishop
          (469)-252-3505
          press@beaconequity.com